24.06.2015 • News

Huntingdon Life Sciences and Harlan Laboratories to become Envigo

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the combined companies will be called Envigo. When the new name and brand is launched later this year it will be a significant milestone for the combined organization, marking great progress in integrating the companies and building on a heritage of more than 80 years.

The name Envigo is made from a combination of words that reflect the identity of the new company. The letters “E and N” come from “enhance, enrich and enable,” … the company helps make the world a better place through advancing the research and product development of its customers. “VIGO” originates in “vigorous and invigorate”, and the Latin word “vita” meaning “life”… so being dynamic and strong, imparting vitality, energy and life.

Brian Cass, CEO, commented: “This is a hugely exciting time for our company. We at Envigo will be united with our customers in the knowledge that the research they conduct, and the products we help them develop, have the potential to enhance life. Our new name and brand will reflect our integrated management structure and the broader product and service offerings of our combined organization.”

Adrian Hardy, COO, added: “Our customers are looking for partners who understand their goals, take ownership of projects, and deliver high quality products and science. Our goal is to establish Envigo as the number one partner for both customer service and scientific expertise.”

The combined organization has 3,800 people and sales approaching $500 million. As a result of the integration, the company is the largest provider of research services to the crop protection and chemical industries, the second largest supplier of research models and services, and the third largest in the preclinical pharmaceutical development arena.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.